CONMED Corporation (CNMD)
NYSE: CNMD · IEX Real-Time Price · USD
75.31
+0.59 (0.79%)
May 20, 2024, 4:00 PM EDT - Market closed
CONMED Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for CONMED stock have an average target of 106.63, with a low estimate of 75 and a high estimate of 141. The average target predicts an increase of 41.59% from the current stock price of 75.31.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CONMED stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $107 | Strong Buy | Reiterates | $107 | +42.08% | May 6, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $115 → $75 | Buy | Maintains | $115 → $75 | -0.41% | Apr 25, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $98 → $77 | Hold | Maintains | $98 → $77 | +2.24% | Apr 25, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $100 → $95 | Buy | Maintains | $100 → $95 | +26.15% | Apr 25, 2024 |
| Needham | Needham | Strong Buy Maintains $129 → $107 | Strong Buy | Maintains | $129 → $107 | +42.08% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
1.38B
from 1.24B
Increased by 10.63%
Revenue Next Year
1.50B
from 1.38B
Increased by 8.57%
EPS This Year
4.42
from 2.04
Increased by 116.70%
EPS Next Year
5.73
from 4.42
Increased by 29.61%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.4B | 1.6B | 1.7B | 1.8B |
| Avg | 1.4B | 1.5B | 1.6B | 1.7B |
| Low | 1.3B | 1.4B | 1.5B | 1.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 14.4% | 13.0% | 16.2% | 8.6% |
| Avg | 10.6% | 8.6% | 8.8% | 5.5% |
| Low | 5.8% | 2.6% | 1.5% | 1.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 4.58 | 6.09 | 7.32 | 7.85 |
| Avg | 4.42 | 5.73 | 6.81 | 7.63 |
| Low | 4.21 | 5.26 | 6.24 | 7.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 124.4% | 37.8% | 27.7% | 15.2% |
| Avg | 116.7% | 29.6% | 18.9% | 12.0% |
| Low | 106.6% | 19.0% | 8.9% | 7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.